Orthofix Medical Inc. Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax
Orthofix Medical Inc. (OFIX) reported Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax of -$307.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-04-29.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax · last filed 2015-04-29
- Orthofix Medical Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2014 was -$307.00K, a 169.30% decline from fiscal 2013.
- Orthofix Medical Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2013 was $443.00K.
- Orthofix Medical Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2012 was -$416.00K, a 160.03% decline from fiscal 2011.
- Orthofix Medical Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2011 was $693.00K, a 450.00% increase from fiscal 2010.
| Period end | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 12 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 12 month as first filed |
|---|---|---|
| 2014-12-31 | -$307.00K 10-K · filed 2015-04-29 | |
| 2013-12-31 | $443.00K 10-K · filed 2015-04-29 | $442.00K 10-K · filed 2014-03-31 |
| 2012-12-31 | -$416.00K 10-K · filed 2015-04-29 | |
| 2011-12-31 | $693.00K 10-K/A · filed 2015-03-31 | |
| 2010-12-31 | $126.00K 10-K/A · filed 2014-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |